Free shipping on all orders over $ 500

Ixabepilone

Cat. No. M3768

All AbMole products are for research use only, cannot be used for human consumption.

Ixabepilone Structure
Synonym:

Ixempra, BMS-247550, NSC 710428

Size Price Availability Quantity
1mg USD 115  USD115 In stock
5mg USD 240  USD240 In stock
10mg USD 440  USD440 In stock
25mg USD 860  USD860 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Ixabepilone (BMS 247550) is an epothilone B analog and nontaxane microtubule-stabilizing compound. Ixabepilone induces cell cycle arrest at the G(2)-M phase transition and subsequent apoptotic cell death of MDA-MB-468 (468) cells. Ixabepilone, on a once every 21-day schedule, is modestly active against metastatic gastric cancer previously treated with a taxane. The days 1-5 every 21 days schedule had a more favorable safety profile but no activity. The results of this study suggest that once every 21-day ixabepilone schedule should be pursued further in untreated gastric or gastroesophageal adenocarcinoma patients. Ixabepilone has demonstrated activity in patients with chemotherapy-naive metastatic HRPC. Major toxicities were neutropenia and neuropathy. Further testing to define its activity relative to standard therapy is warranted.

Chemical Information
Molecular Weight 506.7
Formula C27H42N2O5S
CAS Number 219989-84-1
Solubility (25°C) DMSO
Storage 2-8°C, protect from light
References

[1] Kim YH, et al. Cancer Chemother Pharmacol. A phase II trial of ixabepilone in Asian patients with advanced gastric cancer previously treated with fluoropyrimidine-based chemotherapy.

[2] Roché H, et al. Clin Breast Cancer. A phase I study of ixabepilone in combination with epirubicin in patients with metastatic breast cancer.

[3] Huang H, et al. Clin Cancer Res. A phase II clinical trial of ixabepilone (Ixempra; BMS-247550; NSC 710428), an epothilone B analog, in patients with metastatic renal cell carcinoma.

Related Microtubule Products
CCB02

CCB02 is a selective CPAP-tubulin interaction inhibitor, binding to tubulin and competing for the CPAP binding site of β-tubulin, with an IC50 of 689 nM, and shows potent anti-tumor activity.

Lisavanbulin

Lisavanbulin (BAL-101553) is the prodrug of the microtubule targeting agent Avanbulin (BAL 27862).

20-O-Demethyl-AP3 

20-O-Demethyl-AP3 is a minor metabolite of Ansamitocin P-3.

Lisavanbulin dihydrochloride

Lisavanbulin (BAL-101553) dihydrochloride is the prodrug of the microtubule targeting agent Avanbulin (BAL 27862).

Paclitaxel-d5

Paclitaxel-d5

  Catalog
Abmole Inhibitor Catalog




Keywords: Ixabepilone, Ixempra, BMS-247550, NSC 710428 supplier, Microtubule, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.